CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY

Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo-Jack, Ralph A Defronzo, Daniel Einhorn, Vivian A. Fonseca, Jeffrey R. Garber, W. Timothy Garvey, George Grunberger, Yehuda Handelsman, Irl B. Hirsch, Paul S. Jellinger, Janet B. McGill, Jeffrey I. Mechanick, Paul D. Rosenblit, Guillermo E. Umpierrez

Research output: Contribution to journalArticle

251 Citations (Scopus)

Abstract

ABBREVIATIONS: A1C = hemoglobin A1C AACE = American Association of Clinical Endocrinologists ACCORD = Action to Control Cardiovascular Risk in Diabetes ACCORD BP = Action to Control Cardiovascular Risk in Diabetes Blood Pressure ACEI = angiotensin-converting enzyme inhibitor ADVANCE = Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation AGI = alpha-glucosidase inhibitor apo B = apolipoprotein B ASCVD = atherosclerotic cardiovascular disease BAS = bile acid sequestrant BMI = body mass index BP = blood pressure CHD = coronary heart disease CKD = chronic kidney disease CVD = cardiovascular disease DASH = Dietary Approaches to Stop Hypertension DPP-4 = dipeptidyl peptidase 4 eGFR = estimated glomerular filtration rate FDA = Food and Drug Administration GLP-1 = glucagon-like peptide 1 HDL-C = high-density lipoprotein cholesterol IMPROVE-IT = Improved Reduction of Outcomes: Vytorin Efficacy International Trial LDL-C = low-density lipoprotein cholesterol LDL-P = low-density lipoprotein particle Look AHEAD = Look Action for Health in Diabetes NPH = neutral protamine Hagedorn OSA = obstructive sleep apnea SFU = sulfonylurea SGLT-2 = sodium glucose cotransporter-2 SMBG = self-monitoring of blood glucose T2D = type 2 diabetes TZD = thiazolidinedione VADT = Veterans Affairs Diabetes Trial.

Original languageEnglish (US)
Pages (from-to)207-238
Number of pages32
JournalEndocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Volume23
Issue number2
DOIs
StatePublished - Feb 1 2017

Fingerprint

Glucagon-Like Peptide 1
perindopril drug combination indapamide
Endocrinology
Apolipoproteins B
Type 2 Diabetes Mellitus
Cardiovascular Diseases
Sodium-Glucose Transport Proteins
Gliclazide
Blood Glucose Self-Monitoring
Blood Pressure
Dipeptidyl Peptidase 4
Protamines
Veterans
Obstructive Sleep Apnea
United States Food and Drug Administration
Bile Acids and Salts
Glomerular Filtration Rate
Chronic Renal Insufficiency
Vascular Diseases
LDL Lipoproteins

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY. / Garber, Alan J.; Abrahamson, Martin J.; Barzilay, Joshua I.; Blonde, Lawrence; Bloomgarden, Zachary T.; Bush, Michael A.; Dagogo-Jack, Samuel; Defronzo, Ralph A; Einhorn, Daniel; Fonseca, Vivian A.; Garber, Jeffrey R.; Garvey, W. Timothy; Grunberger, George; Handelsman, Yehuda; Hirsch, Irl B.; Jellinger, Paul S.; McGill, Janet B.; Mechanick, Jeffrey I.; Rosenblit, Paul D.; Umpierrez, Guillermo E.

In: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, Vol. 23, No. 2, 01.02.2017, p. 207-238.

Research output: Contribution to journalArticle

Garber, AJ, Abrahamson, MJ, Barzilay, JI, Blonde, L, Bloomgarden, ZT, Bush, MA, Dagogo-Jack, S, Defronzo, RA, Einhorn, D, Fonseca, VA, Garber, JR, Garvey, WT, Grunberger, G, Handelsman, Y, Hirsch, IB, Jellinger, PS, McGill, JB, Mechanick, JI, Rosenblit, PD & Umpierrez, GE 2017, 'CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY', Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, vol. 23, no. 2, pp. 207-238. https://doi.org/10.4158/EP161682.CS
Garber, Alan J. ; Abrahamson, Martin J. ; Barzilay, Joshua I. ; Blonde, Lawrence ; Bloomgarden, Zachary T. ; Bush, Michael A. ; Dagogo-Jack, Samuel ; Defronzo, Ralph A ; Einhorn, Daniel ; Fonseca, Vivian A. ; Garber, Jeffrey R. ; Garvey, W. Timothy ; Grunberger, George ; Handelsman, Yehuda ; Hirsch, Irl B. ; Jellinger, Paul S. ; McGill, Janet B. ; Mechanick, Jeffrey I. ; Rosenblit, Paul D. ; Umpierrez, Guillermo E. / CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY. In: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2017 ; Vol. 23, No. 2. pp. 207-238.
@article{24bfdff797ac4a918f3330486df301d6,
title = "CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY",
abstract = "ABBREVIATIONS: A1C = hemoglobin A1C AACE = American Association of Clinical Endocrinologists ACCORD = Action to Control Cardiovascular Risk in Diabetes ACCORD BP = Action to Control Cardiovascular Risk in Diabetes Blood Pressure ACEI = angiotensin-converting enzyme inhibitor ADVANCE = Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation AGI = alpha-glucosidase inhibitor apo B = apolipoprotein B ASCVD = atherosclerotic cardiovascular disease BAS = bile acid sequestrant BMI = body mass index BP = blood pressure CHD = coronary heart disease CKD = chronic kidney disease CVD = cardiovascular disease DASH = Dietary Approaches to Stop Hypertension DPP-4 = dipeptidyl peptidase 4 eGFR = estimated glomerular filtration rate FDA = Food and Drug Administration GLP-1 = glucagon-like peptide 1 HDL-C = high-density lipoprotein cholesterol IMPROVE-IT = Improved Reduction of Outcomes: Vytorin Efficacy International Trial LDL-C = low-density lipoprotein cholesterol LDL-P = low-density lipoprotein particle Look AHEAD = Look Action for Health in Diabetes NPH = neutral protamine Hagedorn OSA = obstructive sleep apnea SFU = sulfonylurea SGLT-2 = sodium glucose cotransporter-2 SMBG = self-monitoring of blood glucose T2D = type 2 diabetes TZD = thiazolidinedione VADT = Veterans Affairs Diabetes Trial.",
author = "Garber, {Alan J.} and Abrahamson, {Martin J.} and Barzilay, {Joshua I.} and Lawrence Blonde and Bloomgarden, {Zachary T.} and Bush, {Michael A.} and Samuel Dagogo-Jack and Defronzo, {Ralph A} and Daniel Einhorn and Fonseca, {Vivian A.} and Garber, {Jeffrey R.} and Garvey, {W. Timothy} and George Grunberger and Yehuda Handelsman and Hirsch, {Irl B.} and Jellinger, {Paul S.} and McGill, {Janet B.} and Mechanick, {Jeffrey I.} and Rosenblit, {Paul D.} and Umpierrez, {Guillermo E.}",
year = "2017",
month = "2",
day = "1",
doi = "10.4158/EP161682.CS",
language = "English (US)",
volume = "23",
pages = "207--238",
journal = "Endocrine Practice",
issn = "1530-891X",
publisher = "American Association of Clinical Endocrinology",
number = "2",

}

TY - JOUR

T1 - CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY

AU - Garber, Alan J.

AU - Abrahamson, Martin J.

AU - Barzilay, Joshua I.

AU - Blonde, Lawrence

AU - Bloomgarden, Zachary T.

AU - Bush, Michael A.

AU - Dagogo-Jack, Samuel

AU - Defronzo, Ralph A

AU - Einhorn, Daniel

AU - Fonseca, Vivian A.

AU - Garber, Jeffrey R.

AU - Garvey, W. Timothy

AU - Grunberger, George

AU - Handelsman, Yehuda

AU - Hirsch, Irl B.

AU - Jellinger, Paul S.

AU - McGill, Janet B.

AU - Mechanick, Jeffrey I.

AU - Rosenblit, Paul D.

AU - Umpierrez, Guillermo E.

PY - 2017/2/1

Y1 - 2017/2/1

N2 - ABBREVIATIONS: A1C = hemoglobin A1C AACE = American Association of Clinical Endocrinologists ACCORD = Action to Control Cardiovascular Risk in Diabetes ACCORD BP = Action to Control Cardiovascular Risk in Diabetes Blood Pressure ACEI = angiotensin-converting enzyme inhibitor ADVANCE = Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation AGI = alpha-glucosidase inhibitor apo B = apolipoprotein B ASCVD = atherosclerotic cardiovascular disease BAS = bile acid sequestrant BMI = body mass index BP = blood pressure CHD = coronary heart disease CKD = chronic kidney disease CVD = cardiovascular disease DASH = Dietary Approaches to Stop Hypertension DPP-4 = dipeptidyl peptidase 4 eGFR = estimated glomerular filtration rate FDA = Food and Drug Administration GLP-1 = glucagon-like peptide 1 HDL-C = high-density lipoprotein cholesterol IMPROVE-IT = Improved Reduction of Outcomes: Vytorin Efficacy International Trial LDL-C = low-density lipoprotein cholesterol LDL-P = low-density lipoprotein particle Look AHEAD = Look Action for Health in Diabetes NPH = neutral protamine Hagedorn OSA = obstructive sleep apnea SFU = sulfonylurea SGLT-2 = sodium glucose cotransporter-2 SMBG = self-monitoring of blood glucose T2D = type 2 diabetes TZD = thiazolidinedione VADT = Veterans Affairs Diabetes Trial.

AB - ABBREVIATIONS: A1C = hemoglobin A1C AACE = American Association of Clinical Endocrinologists ACCORD = Action to Control Cardiovascular Risk in Diabetes ACCORD BP = Action to Control Cardiovascular Risk in Diabetes Blood Pressure ACEI = angiotensin-converting enzyme inhibitor ADVANCE = Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation AGI = alpha-glucosidase inhibitor apo B = apolipoprotein B ASCVD = atherosclerotic cardiovascular disease BAS = bile acid sequestrant BMI = body mass index BP = blood pressure CHD = coronary heart disease CKD = chronic kidney disease CVD = cardiovascular disease DASH = Dietary Approaches to Stop Hypertension DPP-4 = dipeptidyl peptidase 4 eGFR = estimated glomerular filtration rate FDA = Food and Drug Administration GLP-1 = glucagon-like peptide 1 HDL-C = high-density lipoprotein cholesterol IMPROVE-IT = Improved Reduction of Outcomes: Vytorin Efficacy International Trial LDL-C = low-density lipoprotein cholesterol LDL-P = low-density lipoprotein particle Look AHEAD = Look Action for Health in Diabetes NPH = neutral protamine Hagedorn OSA = obstructive sleep apnea SFU = sulfonylurea SGLT-2 = sodium glucose cotransporter-2 SMBG = self-monitoring of blood glucose T2D = type 2 diabetes TZD = thiazolidinedione VADT = Veterans Affairs Diabetes Trial.

UR - http://www.scopus.com/inward/record.url?scp=85020541426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020541426&partnerID=8YFLogxK

U2 - 10.4158/EP161682.CS

DO - 10.4158/EP161682.CS

M3 - Article

VL - 23

SP - 207

EP - 238

JO - Endocrine Practice

JF - Endocrine Practice

SN - 1530-891X

IS - 2

ER -